Dr. Robert M. Califf

House Committee on Oversight and Accountability chairman James Comer announced the investigation into the Food and Drug Administration’s (FDA) failure to regulate cannabidiol (CBD) products as dietary supplements. What Happened: After organizing a high-level internal working group to examine...